Mor Lab | Publications
Publications
A note on the significance of the author list order. Last author position is usually, but not always, reserved to the author of correspondence who is responsible for the research design and manuscript writing and its final form. The “First Author” position in the case of primary research publications is reserved to the person most intimately connected with carrying out the experiments and drafting the manuscript. In review articles, the first author is usually the person who most substantially contributed to the writing of the manuscript. Middle authors usually contributed to the research by carrying out some of the experiments or substantially assisting in the experiments, intellectual input, experimental design, and writing parts of the manuscripts etc. On occasions, two equally contributing authors deserve to be recognized as “Co-First Authors”.
An asterisk (*) denotes members of the Mor lab. A section sign (§) denotes the author of correspondence. Co-First Authors are recognized by a superscripted 1 (1). Conference abstracts are all posters unless stated otherwise and the presenting author’s name is underlined.
1. *Larrimore KE, *Barcus MJ, *Kannan L, Gao Y, Zhan C-G, Brimijoin S, §Mor TS (2012) Plants as a source of butyrylcholinesterase variants designed for enhanced cocaine hydrolase activity. Chem-Biol Interact. In press.
2. *Geyer BC, Ben-Ari S, §Mor TS and §Soreq H (2012) Nicotinic stimulation induces Tristetraprolin over-production and attenuates inflammation in muscle. Biochim Biophys Acta. 823: 368-78
3. *Matoba N, *Shah NR, and §Mor TS (2011) Humoral Immunogenicity of an HIV-1 Envelope Residue 649-684 membrane-proximal Region Peptide Fused to the Plague Antigen F1-V. Vaccine. 29:5584-5590.
4. *1Geyer BC, *1Kannan L, *Garnaud PE, Broomfield CA, Cadieux CL, *Cherni I, Hodgins SM, Kasten SA, Kelley K, *Kilbourne J, Oliver ZP, Otto TC, *Puffenberger I, Reeves TE, *Robbins N, 2nd, *Woods RR, Soreq H, Lenz DE, Cerasoli DM, §Mor TS (2010) Plant-derived human butyrylcholinesterase, but not an organophosphorous-compound hydrolyzing variant thereof, protects rodents against nerve agents. Proc Natl Acad Sci U S A 107: 20251-20256
5. *1Geyer, BC, *Kannan, L, *Cherni, I, *Woods, RR, *Soreq, H, and §Mor TS (2010) Transgenic plants as a source for the bioscavenging enzyme, human butyrylcholinesterase. Plant Biotechnol J 8: 873-886
6. *Matoba N, Kajiura H, *Cherni I, *Doran JD, Alfsen A, Bomsel M, Fujiyama K and §Mor TS (2009) Biochemical and immunological characterization of the plant-derived candidate HIV-1 mucosal vaccine CTB‑MPR649‑684. Plant Biotechnol J 7:129-145
7. *1Woods RR, *1Geyer BC, §Mor TS (2008) Production of recombinant human acetylcholinesterase in hairy root cultures. BMC Biotechnol 8:95
8. *1Geyer BC, *1Woods RR, §Mor TS (2008) Increased organophosphate scavenging in a butyrylcholinesterase mutant. Chem Biol Interact 175:376-379
9. *Matoba N, *Griffin TA, *Mittman M, *Doran JD, Alfsen A, Montefiori DC, Hanson CV, Bomsel M, §Mor TS (2008) Transcytosis-blocking abs elicited by an oligomeric immunogen based on the membrane proximal region of HIV-1 gp41 target non-neutralizing epitopes. Curr HIV Res 6:218-229
10. Mor I, Sklan EH, Podoly E, Pick M, Kirschner M, Yogev L, Bar-Sheshet Itach S, Schreiber L, *Geyer B, Mor T, Grisaru D, Soreq H (2008) Acetylcholinesterase-R increases germ cell apoptosis but enhances sperm motility. J Cell Mol Med 12:479-95
11. Berson A, Knobloch M, Hanan M, Diamant S, Sharoni M, Schuppli D, *Geyer BC, Ravid R, Mor TS, Nitsch RM and §Soreq H (2008) Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology. Brain 131:109-119
12. *1Geyer BC and *1Fletcher SP, *Griffin TA, *Lopker MJ, Soreq H and §Mor, TS (2007) Translational control of recombinant human acetylcholinesterase accumulation in plants. BMC Biotechnol 7:24
13. 1Evron T and *1Geyer BC, *Cherni I, *Muralidharan M, *Kilbourne J, *Fletcher SP, Soreq H and §Mor TS (2007) Plant-derived human acetylcholinesterase-R provides protection from lethal organophosphate poisoning and its chronic aftermath. FASEB J 21:2961-9
14. Evron T, Greenberg D, Mor TS and §Soreq H (2007) Adaptive changes in acetylcholinesterase gene expression as mediators of recovery from chemical and biological insults. Toxicology 233, 97-107
15. *Matoba N, *Geyer BC, *Kilbourne J, Alfsen A, Bomsel M and §Mor TS (2006) Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR649-684, a mucosal subunit HIV/AIDS vaccine candidate. Vaccine 24:5047-5055
16. Saldaña S, Guadarrama FE, de Jesús Olivera Flores T, Arias N, López S, Arias C, Ruiz R, Mason H, Mor TS, Richter L, Arntzen CJ and §Gómez Lim MA. (2006) Production of rotavirus-like-particles in tomato (Lycopersicon esculentum L.) fruit by expression of capsid proteins VP2 and VP6 and immunological studies. Viral Immunol 19:42-53
17. *Geyer BC, *Muralidharan M, *Cherni I, *Doran J, *Fletcher SP, Evron, T, Soreq H and §Mor TS (2005) Purification of Transgenic Plant-Derived Recombinant Human Acetylcholinesterase-R. Chem Biol Interact 157-158:406-407
18. *Muralidharan M, Soreq H and §Mor, TS (2005) Characterizing Pea Acetylcholinesterase. Chem Biol Interact 157-158:331-334
19. *Matoba N, Magérus A, *Geyer BC, Zhang Y, *Muralidharan M, Alfsen A, Arntzen CJ, Bomsel M and §Mor TS (2004) Mucosally-targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking antibodies. Proc Natl Acad Sci USA 101:13584–13589
20. *Fletcher SP, *Geyer BC, Smith A, Evron T, Joshi L, Soreq H and §Mor TS (2004) Tissue distribution of cholinesterases and anticholinesterases in native and transgenic tomato plants. Plant Mol Biol 55:33-44
21. Mor TS, Moon Y-S, Palmer, KE and §Mason, HS (2003) Geminivirus vectors for high level expression of foreign proteins in plant cells. Biotechnol Bioeng 81: 430-437
22. Mason HS, Warzecha H, Mor TS and §Arntzen CJ (2002) Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine, Trends Mol Med 8, 324-9
23. §Mor TS, Sternfeld M, Arntzen CJ, Soreq H and Mason, HS (2001) Expression of recombinant human acetylcholinesterase in transgenic tomato plants. Biotechnol Bioeng 75:259-266
24. §Mor TS, Gómez-Lim MA and Palmer, KE (1998) Edible plant vaccines: A concept coming of age. Trends Microbiol 6:449-453
25. Mor TS, Hundal T, §Ohad I and §Andersson B (1997) The fate of cytochrome b559 during anaerobic photoinhibition and its recovery processes Photosynth Res 53:205-213
26. Mor TS, Ohad I, Hirschberg J and §Pakrasi HB (1995) An unusual organization of the genes encoding cytocrhome b559 in Chlamydomonas reinhardtii: psbE and psbF genes are separately transcribed from different regions of the plastid chromosome. Mol Gen Genet 246:600-604
27. Anbudurai PA, Mor TS, Ohad I, Shestakov SV and §Pakrasi HB (1994) The ctpA gene encodes the c-terminal processing protease for the D1 of the photosystem II reaction center complex Proc Natl Acad Sci USA 91:8082-8086
28. Mor TS, Post AF and §Ohad I (1993) The Manganese stabilizing protein (MSP) of Prochlorothrix hollandica is a hydrophobic membrane bound protein Biochim Biophys Acta 1141:206-212
Book Chapters:
1. *Geyer GC, Evron T, §Mor TS and §Soreq H (2009) Organophosphate Intoxication: Molecular Consequences, Mechanisms and Solutions. In Toxicology of Chemical Warfare Agents (Gupta R, Editor) 691-717. Elsevier Inc, San Diego
2. *Matoba N and §Mor TS (2006) Plant-derived subunit vaccines, In Plant Genetic Engineering Vol. 7 B: Metabolic Engineering & Molecular Pharming (Jaiwal PK, Ed) pp 143-183. Studium Press, Houston
3. §Mor TS, Mason HS, Kirk DD, Arntzen CJ and Cardineau GA (2004) Plants as a production and delivery vehicle for orally delivered subunit vaccines. In Current Vaccines 3rd Edition (Levine M, Ed) pp 305-312, Marcel Dekker, New York
4. §Mor TS and Mason HS (2004) Transgenic plants as a source for subunit vaccines. In: Handbook of Plant Biotechnology (Christou P and Klee H, Eds) pp 768-780, John Wiley & Sons Ltd, West Sussex
5. §Mor TS and Soreq H (2004) Human cholinesterases from plants for detoxification. In Encyclopedia of Plant & Crop Science (Goodman RM, Ed) pp 564-567, Marcel Dekker, New York
6. Mor TS and §Arntzen CJ (2003) Plants and Human Health: Delivery of vaccines via transgenic plants. In Plant Biotechnology 2002 and Beyond (Vasil, JK, Ed) pp 383-387, Kluwer Academic Publishers, Dordrecht
7. Mor TS, Richter, L and §Mason HS (1999) Expression of rotavirus proteins in transgenic plants. In Plant Biotechnology and In-Vitro Biology in the 21st Century (Altman A, Ziv M and Izhar S, Eds) pp 521-524, Kluwer Academic Publishers, Dordrecht
8. Mor TS and §Arntzen CJ (1999) Pharmaceutical foodstuffs: oral immunization with transgenic plants. In Plant Biotechnology and In-Vitro Biology in the 21st Century (Altman A, Ziv M and Izhar S, Eds) pp 17-20, Kluwer Academic Publishers, Dordrecht
9. Domovich Y, Mor TS, Oetmüller R, Herrman RG and §Ohad I (1995) Reversible dissociation of the OEC proteins from the lumenal side of the thylakoid membrane during photoinhibition and recovery. In Photosynthesis: From Light to Biosphere (Mathis P, Ed) Vol IV, pp 311-314, Kluwer Academic Publishers, Dordrecht
10. Mor TS, Pakrasi HB and §Ohad I (1995) The impact of the F26S mutation in the b subunit of cytochrome b559 on the function and stability of photosystem II in tobacco. In Photosynthesis: From Light to Biosphere (Mathis P, Ed) Vol I, pp 927-930, Kluwer Academic Publishers, Dordrecht
11. §Ohad I, Keren N, Zer H, Gong H, Mor TS, Gal A, Tal S and Domovitch Y (1993) Light induced degradation of the photochemical reaction center II D1 protein in-vivo: An integrative approach. In The Proceedings of the 41st Harden Conference on Photoinhibition of Photosynthesis From Molecular Mechanisms to the Field (Baker NR and Bowyer JR, Eds) pp 161-171, Bios Scientific Publishers, Oxford
12. Mor TS, Post, A F, and §Ohad I (1991) Prochlorothrix hollandica is more sensitive to photoinhibition than Chlamydonomans reinhardtii. In Regulation of Chloroplast Biogenesis (Argyroudi-Akoyunoglou JH, Ed) pp 433-438, Plenum Press, New York
13. Mor TS, Post, A F, and §Ohad I (1991) Characterization of the oxygen evolving system of Prochlorothrix hollandica. In Regulation of Chloroplast Biogenesis (Argyroudi-Akoyunoglou JH, Ed) pp 427-432, Plenum Press, New York
14. Gal, A, Mor TS, Hauska, G, Herrmann, R and §Ohad I (1990) LHCII kinase activity associated with Isolated Cytochrome b6/f complex. In Current Research in Photosynthesis (Baltscheffski M, Ed) Vol I pp 783-785, Kluver Academic Publishers, Dordrecht
Thesis:
Mor TS (1996) Dynamics of Photosystem II: Structural and Functional Aspects of Proteins Associated with the Reaction Center. Academon Press, Jerusalem
Abstracts (Since 2002, Partial List)
1. *Gong Z, *Kessans SA, §Mor TS and §Fromme P. Production and Purification of Recombinant Truncated HIV-1 gp41 Consisting of the Membrane Proximal and Transmembrane Domains for Structure Determination. Keystone Structural Biology Meeting. Keystone, Colorado. 22 January 2012.
2. *Kessans SA, *Linhart M, Matoba N, and §Mor TS. Biochemical and immunological characterization of plant-produced HIV-1 Gag/dgp41 enveloped virus-like particles. Keystone Structural Biology Meeting. Keystone, Colorado. 22 January 2012.
3. *Larrimore KE, Kannan L, *Robbins II N, *Garnaud PE, *Geyer B, *Woods R and §Mor TS. Selection of translation start site in transcripts of a human gene expressed in plants. American Society of Plant Biologists: Plant Biology 2011. Minneapolis, MN. 6-10 August 2011. Poster Presentation (Travel grant and Honorable Mention).
4. *Kessans SA and §Mor TS. Towards the production of a mucosally-targeted HIV subunit vaccine. . PBVA 4: Plant Expression Systems for Recombinant Pharmacologics. Porto, Portugal. 8-10 June 2011. (Oral presentation
5. §Mor TS. Transgenic plants as a source for the bioscavenging enzyme, human butyrylcholinesterase. Chemical and Biological Defense Science and Technology (CBD S&T) Conference. Las Vegas, NV. 14-18 November 2011.
6. *Robbins II NE, *Kannan L, and §Mor TS. Improvements to the Production Platform for Plant-Produced Butyrylcholinesterase. ASPB Western Section Meeting. Long Beach, CA. 26 February 2011.
7. Schneider JD, §Mor TS, Loos A, Castilho A, Grass J, and §Steinkellner H. Expression of acetyl- and butyrylcholinesterase in Nicotiana benthamiana with a human-like glycosylation profile. PBVA 4: Plant Expression Systems for Recombinant Pharmacologics. Porto, Portugal. 8-10 June 2011
8. Schneider JD, §Mor TS, Loos A, Castilho A, Grass J, and §Steinkellner H. Expression of acetyl- and butyrylcholinesterase in Nicotiana benthamiana with a human-like glycosylation profile. PBVA 4: Plant Expression Systems for Recombinant Pharmacologics. Porto, Portugal. 8-10 June 2011
9. *Kessans SA, *Frater J, *Matoba N, and §Mor T. Plant expression of chimeric Gag/gp41 virus-like particles as a mucosally-targeted subunit vaccine against HIV-1. Arizona BIOFest 2010. Scottsdale, Arizona. 27 October 2010
10. *Kannan L, *Geyer BC, *Garnaud PE, Broomfield CA, Cadieux CL, *Cherni I, Hodgins SM, Kasten SA, Kelley K, *Kilbourne J, Oliver ZP, Otto TC, *Puffenberger I, Reeves TE, *Robbins N, 2nd, *Woods RR, Soreq H, Lenz DE, Cerasoli DM, §Mor TS (2010) Plant-derived human butyrylcholinesterase, but not an organophosphorous-compound hydrolyzing variant thereof, protects rodents against nerve agents. Arizona BIOFest 2010. Scottsdale, Arizona. 27 October 2010
11. *Kessans SA, *Frater J, *Matoba N, and §Mor T. Plant expression of chimeric Gag/gp41 virus-like particles as a mucosally-targeted subunit vaccine against HIV-1. National Academy of Engineering Grand Challenges Summit 2010. Phoenix, Arizona. 8-9 April 2010
12. §Mor, TS. Rapid and large-scale plant-based production of catalytic nerve agent bioscavengers. 4th Annual NIH CounterACT Network Research Symposium, San Francisco, CA, June 22-24, 2010.
13. *Matoba N, *Cherni I, *Kessans S, *Frater J, *Preston K, Bomsel M, and §Mor TS. Biochemical and immunological characterization of the plant-derived candidate HIV-1 mucosal vaccine CTB-MPR. AIDS Vaccine 2009. Paris, France. 19–22 October 2009. (published in Retrovirology 2009, 6(Suppl 3):P182).
14. *Kessans SA, *Frater J, Matoba N, and §Mor T. Plant expression of chimeric Gag/gp41 virus-like particles as a mucosally-targeted subunit vaccine against HIV-1. AIDS Vaccine 2009. Paris, France. 19–22 October 2009. (published in Retrovirology 2009, 6(Suppl 3):P15).
15. *Muralidharan M, *Woodberry K, *Benally AJ, *Kannan L and §Mor TS. Plant cholinesterases – a reality check. The Xth International Meeting on Cholinesterases. Šibenik, Croatia, 20-25 September 2009
16. *Geyer BC, Kilbourne J, §Mor TS. Recombinant protein antidotes for the treatment of succinylcholine apnea and organophosphate poisoning. Society for Academic Emergency Medicine Annual Meeting. New Orleans, LA. May 14 – 17 2009
17. §Mor, TS. Rapid and large-scale plant-based production of catalytic nerve agent bioscavengers. 3rd Annual CounterACT Network Research Symposium Washington, DC, April 14 - 16, 2009.
18. *Cherni I, *Vassal A, *Kessans S, *Matoba N, and §Mor TS. Membrane proximal region-hepatitis B core antigen fusion virus-like particles and their immunogenicity in mice. AIDS Vaccine 2008. Cape Town, South Africa, Oct 13-16, 2008. Student Travel Awardee
19. *Geyer BC, Kilbourne J, §Mor TS. Advanced Bioscavengers for the emergency treatment of nerve agent / pesticide poisoning. American College of Emergency Physicians Scientific Assembly. Chicago, IL. September 27-30 2008
20. *Garnaud P-EE, *Kannan L, *Puffenberger I, §Mor TS. Rapid and large-scale plant-based production of catalytic nerve-agent bioscavenger paraoxonase-1. 3rd International Conference on Paraoxonases, Los Angeles, CA, September 7–10 2008
21. *Geyer BC, Ben-Ari S, *Delisle J, Soreq H, and §Mor TS. Cholinergic Excitation Modulates Chemokine Signaling in Skeletal Muscle. XIII International Symposium on Cholinergic Mechanisms. Foz do Iguaçu - Brazil, August 16-20 2008
22. *Matoba N, Kajiura H, *Cherni I, *Doran JD, Bomsel M, Fujiyama K, and §Mor TS. In planta expression and molecular characterization of the candidate HIV-1 mucosal vaccine CTB-MPR649–684. P-1002 (Talk). 2008 World Congress on In Vitro Biology, Tucson, AZ, June 14-18 2008
23. *Kannan L, *Geyer BC, *Garaud P-E, *Woods RR, *Muralidharan M, *Cherni I, and §Mor TS. Partial characterization and purification of plant derived butyrylcholinesterase to treat organophosphate poisoning. P-2011. 2008 World Congress on In Vitro Biology, Tucson, AZ, June 14-18 2008 (This poster was selected for an oral poster presentation)
24. *Cherni I, *Vassal A, *Matoba N, and §Mor TS. MPR649-684-Hep B Core Antigen fusion forms virus-like particles in plants and is immunogenic in mice. P-2013. 2008 World Congress on In Vitro Biology, Tucson, AZ, June 14-18 2008
25. *Garnaud P-EE, *Kannan L, and §Mor TS. Rapid and large-scale plant-based production of catalytic nerve-agent bioscavenger paraoxonase-1. P-2016. 2008 World Congress on In Vitro Biology, Tucson, AZ, June 14-18 2008
26. §Mor TS, *Geyer BC, *Muralidharan M, *Cherni I, Fletcher SP, Evron T, and Soreq H. Plant Produced Human Cholinesterases and Plant Cholinesterase. P-2021. 2008 World Congress on In Vitro Biology, Tucson, AZ, June 14-18 2008
27. *Muralidharan M, * Skalecka-Ball A, and §Mor TS. Characterizing cholinesterase like enzyme in A. thaliana. P-2035. 2008 World Congress on In Vitro Biology, Tucson, AZ, June 14-18 2008. (This poster was selected for an oral poster presentation and won First Prize in the poster competition)
28. *Kessans S, §Mor TS, and *Matoba N. Plant Expression of chimeric Gag/gp41 virus-like particles as a subunit vaccine against HIV-1. P-2051. 2008 World Congress on In Vitro Biology, Tucson, AZ, June 14-18 2008.
29. *Namrata Shah, *Matoba N, *Chang H, *Hu J, and §Mor TS. Plague antigen fusions with gp41 membrane proximal region as HIV vaccine candidate. P-2052. 2008 World Congress on In Vitro Biology, Tucson, AZ, June 14-18 2008.
30. *Delisle JP, *Geyer BC, and §Mor TS. Characterizing the cholinergic anti-inflammatory pathway in skeletal muscles. A-3005. 2008 World Congress on In Vitro Biology, Tucson, AZ, June 14-18 2008
31. §Mor, TS. Rapid and large-scale plant-based production of catalytic nerve agent bioscavengers. CounterACT – Countermeasures against Chemical Threats – 2nd Annual Network Research Symposium, Washington, DC, April 15-17, 2008.
32. *Matoba N, *Griffin TA, *Mittman M, *Doran JD, Alfsen A, Montefiori DC, Hanson CV, Bomsel M, §Mor TS. Transcytosis-blocking Abs target non-neutralizing epitopes in the membrane proximal region of the HIV-1 envelope protein gp41. 2008 STI/TM CRC Annual Meeting, Chapel Hill, NC, April 13-14, 2008
33. *Matoba N, *Griffin TA, *Mittman M, *Doran JD, Alfsen A, Montefiori DC, Hanson CV, Bomsel M, §Mor TS. Transcytosis-blocking Abs target non-neutralizing epitopes in the membrane proximal region of the HIV-1 envelope protein gp41. HIV vaccines: Progress and Prospects, Keystone Symposium, Banff, AB, Canada, March 27-April 1, 2008
34. *Matoba N, *Mittman M, *Griffin TA, *Cherni I, and §Mor, TS. Expression of a mucosal subunit HIV-1 vaccine candidate in transgenic N. benthamiana. Talk. In Annual meeting of Japan Society for Bioscience, Biotechnology, and Agrochemistry, Tokyo, Japan, March 2007
35. *Matoba N, *Mittman M, *Griffin TA, *Cherni I, Arntzen CJ, and §Mor TS. Expression of an HIV-1 vaccine candidate expressed in N. benthamiana plants. PBVA 2: Plant Expression Systems for Recombinant Pharmacologics, Verona, Italy, June 18-20 2007
36. *Geyer BC and Ben-Ari, S *Delisle JD, Soreq H and §Mor TS. The “readthrough” variant of acetylcholinesterase abrogates anticholinesterase-induced immunosupression by stimulating TNFa production in murine skeletal muscle. The IXth International Meeting on Cholinesterases, Suzhou, China, 6-10 May 2007
37. §Mor, TS. Rapid and large scale plant-based production of catalytic nerve agent bioscavengers. CounterACT – Countermeasures against Chemical Threats – 1st Annual Network Research Symposium, Arlington, VA, April 25-27, 2007.
38. *Matoba N, *Mittman M, *Griffin TA, *Cherni I, and §Mor TS. Expression of a mucosal subunit HIV-1 vaccine candidate in transgenic N. benthamiana. Talk. Annual meeting of Japan Society for Bioscience, Biotechnology, and Agrochemistry, Tokyo, Japan, March 2007
39. *Cherni I, *Geyer BC, *Matoba N and §Mor TS. MPR649-684-HBsAg Fusion as a Vaccine Candidate against HIV-I Infection. International AIDS Vaccine 2006 Conference, Amsterdam, The Netherlands, August 29 - September 1, 2006
40. *Geyer BC and Ben-Ari S *Cherni I, Evron E, Soreq H and §Mor TS. Preventable Induction of Muscle Alternative Splicing in Organophosphate-Exposed Mice Treated with Recombinant Human Acetylcholinesterase. Genomes, Evolution, & Bioinformatics (GEB2006), Tempe, AZ, May 24-May 28, 2006
41. *Chelladurai SA, Muralidharan M, and §Mor, TS. Gene expression analysis for cholinesterase homologs in plants Genomes, Evolution, & Bioinformatics (GEB2006), Tempe, AZ, May 24-May 28, 2006
42. *Muralidharan M, Soreq H and §Mor, TS. Characterizing a cholinesterase homologue in plants. Genomes, Evolution, & Bioinformatics (GEB2006), Tempe, AZ, May 24-May 28, 2006
43. *Geyer BC and Evron E, *Cherni I, *Muralidharan M, *Kilbourne J, *Fletcher SP, Soreq H and §Mor TS. Plant-erived human acetylcholinesterase-R provides protection from lethal organophosphate poisoning and its chronic aftermath. Bioscience Medical Defense Review 2006 (The U.S. Army Medical Research Institute of Chemical Defense), Hunt Valley, MD, June 4-9 2006
44. *Matoba N, Magérus A, *Geyer BC, Alfsen A, Hanson CV, Arntzen CJ, Bomsel M and §Mor TS. Humoral immunity induced by CTB-MPR649-684 towards the prevention of HIV-1 mucosal transmission/infection”. 12th International Congress of Mucosal Immunology, Boston, MA, June 24 – 30, 2005
45. *Matoba M, Magerus A, *Geyer BC, *Zhang Y, Alfsen A, Arntzen CJ, Bomsel M and §Mor TS. Towards an oral plant-derived HIV-1 subunit vaccine. Poster and Talk. Plant-Based Vaccines & Antibodies. PBVA 2005, Prague, Czech Republic, June 8-10, 2005
46. *Matoba M, Magerus A, *Geyer BC, Alfsen A, Arntzen CJ, Bomsel M and §Mor TS (2005) Humoral immunity induced by CTB-P1 for the prevention of HIV-1 mucosal transmission/infection. Poster and Talk. Plant-Based Vaccines & Antibodies. PBVA 2005, Prague, Czech Republic, June 8-10, 2005
47. *Geyer BC, Evron T, *Cherni I, *Muralidharan M, *Patel A, *Fletcher S, Soreq H and §Mor TS (2005) N. benthamiana produced human acetylcholinesterase completely protects mice from lethal doses of organophosphate toxins. Annual Meeting of the American Society of Plant Biologists, Seattle, WA, July 16-20, 2005
48. *Matoba M, Magerus A, *Geyer BC, *Zhang Y, Alfsen A, Arntzen CJ, Bomsel M and §Mor TS. Towards an oral plant-derived HIV-1 subunit vaccine. HIV vaccine development: Progress and Prospects, Keystone Symposium, Banff, AB, Canada, April 9-15, 2005
49. *Matoba M, Magerus A, *Geyer BC, *Zhang Y, *Alfsen A, Arntzen CJ, Bomsel M and §Mor TS. Humoral immunity induced by CTB-P1 for the prevention of HIV-1 mucosal transmission/infection. HIV Vaccine Development: Progress and Prospects, Keystone Symposium, Banff, AB, Canada, April 9-15, 2005
50. *Muralidharan M, *Fletcher SP, *Geyer BC, Soreq H and §Mor TS (2004) Characterizing pea acetylcholinesterase. VIIIth International Meeting on Cholinesterases, Perugia, Italy, September 26-30, 2004
51. *Matoba N, §Mor TS and Arntzen CJ (2004) Heat-stable oral vaccines from transgenic plants. Talk. Pharmaceutical Sciences World Congress 2004, Kyoto, Japan, May 30–June 3, 2004
52. *Fletcher SP, *Geyer B, *Muralidharan M, Arntzen CJ, Soreq H and §Mor TS (2004) Chemical warfare countermeasures: Expression of human acetylcholinesterase in plants. Gordon Research Conference in Plant Molecular Biology, Plymouth, NH, July 18-23, 2004.
53. *Matoba M, Magerus A, *Geyer BC, *Zhang Y, Alfsen A, *Arntzen CJ, Bomsel M and §Mor TS (2004) A subunit vaccine candidate to prevent HIV-1 transmission. HIV Vaccine Development: Progress and Prospects, Keystone Symposium, Whistler, BC, Canada, April 10-15, 2004
54. *Fletcher SP, *Geyer B, *Muralidharan M, Joshi L, Soreq H and §Mor TS (2003) Transgenic plants expressing human acetylcholinesterase: what they may do for us and what we may learn from them. ISPMB Congress 2003:S26-20. International Congress of Plant Molecular Biology, Barcelona, Spain, June 23-28, 2003
55. *Fletcher SP, *Geyer B, *Muralidharan M, Arntzen CJ, Soreq H and §Mor TS (2003) Chemical warfare countermeasures: Expression of human acetylcholinesterase in plants. Poster and Talk. In-vitro Cell Dev Biol Plant 39:28-A. Congress on in vitro Biology, Portland, OR, May 31-June 04, 2003
56. *Matoba N, Bomsel M, Arntzen CJ and §Mor TS (2003) Towards a mucosal vaccine against HIV. Poster and Talk. In-vitro Cell Dev Biol Plant 39:23-A. Congress on in vitro Biology, Portland, OR, May 31-June 04, 2003
57. *Fletcher SP, *Geyer B, Soreq H and §Mor TS (2002) Acetylcholinesterase and plants: an inquiry to plant biochemistry and a biotechnology application. Plant Physiol (Rockville) 2002:182. Annual Meeting of the American Society of Plant Biologists on Plant Biology Denver, CO, August 3-7, 2002
58. *Muralidharan M, *Geyer B, Soreq H and §Mor TS (2002) Role for acetylcholinesterase in gravitropic responses. Plant Physiol (Rockville) 2002:114. Annual Meeting of the American Society of Plant Biologists on Plant Biology, Denver, CO, August 3-7, 2002
Manuscripts Undergoing Revision
1. Muralidharan M, Woodbury K, and §Mor TS. The Arabidopsis thaliana ortholog of a purported maize cholinesterase gene encodes a GDSL-lipase. Submitted to Plant Molecular Biology
Manuscripts in Preparation
1. *Cherni I, *Geyer BC, Wang K and §Mor TS Expression of recombinant acetylcholinesterase in maize. (figures, draft-text) Biotechnology Progress
2. *Kessans SA, *Frater J, Matoba N, and §Mor T. Plant expression of chimeric Gag/gp41 virus-like particles as a mucosally-targeted subunit vaccine against HIV-1.
